Showing results (41-50 of 101) with videos related to
Sort By:
Pageof 11
Frontiers in Immunology|August 6, 2026
Mapping immune responses to TAK-003 dengue vaccine: immunogenicity across the clinical development programSanja Mandaric, Tarek El Hindi, Eduardo J M Nascimento, et al.The Journal of Infectious Diseases|March 13, 2024
Protective Role of NS1-Specific Antibodies in the Immune Response to Dengue Virus Through Antibody-Dependent Cellular CytotoxicityLuis A Sanchez-Vargas, Anuja Mathew, Henrik Salje, et al.Journal of Virology|December 22, 2006
CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patientsChristof Geldmacher, Jeffrey R Currier, Eva Herrmann, et al.Plos Neglected Tropical Diseases|December 18, 2018
Protective versus pathologic pre-exposure cytokine profiles in dengue virus infectionHeather Friberg, Coreen M Beaumier, Sangshin Park, et al.Msphere|January 24, 2020
Cell-Mediated Immunity Generated in Response to a Purified Inactivated Vaccine for Dengue Virus Type 1Heather Friberg, Luis J Martinez, Leyi Lin, et al.Nature Communications|March 25, 2018
Transcriptomic signatures of NK cells suggest impaired responsiveness in HIV-1 infection and increased activity post-vaccinationMargaret C Costanzo, Dohoon Kim, Matthew Creegan, et al.Human Vaccines & Immunotherapeutics|March 5, 2019
Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regionsPhilippe Moris, Kristen M Bauer, Jeffrey R Currier, et al.Scientific Reports|June 5, 2020
Analysis of cell-associated DENV RNA by oligo(dT) primed 5' capture scRNAseqMark A Sanborn, Tao Li, Kaitlin Victor, et al.Human Immunology|June 29, 2004
HLA-A and -B allele expression and ability to develop anti-Gag cross-clade responses in subtype C HIV-1-infected EthiopiansGuido Ferrari, Jeffrey R Currier, Matthew E Harris, et al.Nature Microbiology|April 1, 2024
Low-dose dengue virus 3 human challenge model: a phase 1 open-label studyAdam T Waickman, Krista Newell, Joseph Q Lu, et al.Pageof 11